The Bellvitge University Hospital, is a public hospital located in town of l'Hospitalet de Llobregat, with an outstanding care, teaching and researching activity. It is specialized in high complexity medical care. It offers all the medical specialties, except for pediatrics and obstetrics.

During the past decade, Hospital Universitari de Bellvitge conducted 277 clinical trials. In the 10-year time frame, 277 clinical trials started and 79 clinical trials were completed, i.e. on average, 28.5% percent of trials that started reached the finish line to date. In the past 5 years, 122 clinical trials started and 42 clinical trials were completed. i.e. 34.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari de Bellvitge" #1 sponsor was "Hospital Universitari de Bellvitge" with 47 trials, followed by "Pfizer" with 19 trials sponsored, "Boehringer Ingelheim" with 15 trials sponsored, "Gilead Sciences" with 14 trials sponsored and "Bayer" with 14 trials sponsored. Other sponsors include 292 different institutions and companies that sponsored additional 193 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari de Bellvitge" #1 collaborator was "Hospital Universitari de Bellvitge" with 15 trials as a collaborator, "Institut d'Investigació Biomèdica de Bellvitge" with 11 trials as a collaborator, "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau" with 9 trials as a collaborator, "Germans Trias i Pujol Hospital" with 9 trials as a collaborator and "Instituto de Salud Carlos III" with 9 trials as a collaborator. Other collaborators include 234 different institutions and companies that were collaborators in the rest 180 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari de Bellvitge" are "Heart Failure" (16 trials), "Coronary Artery Disease" (15 trials), "Amyotrophic Lateral Sclerosis" (10 trials), "COVID-19" (10 trials) and "HIV Infections" (8 trials). Many other conditions were trialed in "Hospital Universitari de Bellvitge" in a lesser frequency.

Most popular intervention types in "Hospital Universitari de Bellvitge" are "Drug" (216 trials), "Device" (67 trials), "Other" (67 trials), "Procedure" (36 trials) and "Biological" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (85 trials), "Remdesivir" (4 trials), "Standard of Care" (4 trials), "Apixaban" (3 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari de Bellvitge" are 386 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 105 active trials in "Hospital Universitari de Bellvitge". 4 are not yet recruiting, 75 are recruiting, 23 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 208 completed trials in Hospital Universitari de Bellvitge, 1 suspended trials, and 53 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari de Bellvitge, 12 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 126 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 54 trials, and there were also 71 trials that are defined as “Not Applicable".

Hospital Universitari de Bellvitge has several departments that took part in Clinical trials: "Hospital Universitari de Bellvitge; Servicio de Neurologia" - 10 trials, "Hospital Duran i Reynals; Servicio de Hematologia" - 7 trials, "Hospital Universitari de Bellvitge; Servicio de Nefrologia" - 6 trials, "Hospital Universitari de Bellvitge ; Servicio de Neumologia" - 4 trials, "Hospital Universitari de Bellvitge; Servicio de Reumatologia" - 3 trials, "Unitat de Pneumologia Experimental" - 2 trials